Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:30 AM
Ignite Modification Date:
2025-12-25 @ 3:30 AM
NCT ID:
NCT04127305
Eligibility Criteria:
Inclusion Criteria:
* Age \> 18
* Informed consent
* Clinical infection indicated for intravenous therapy with at least one of the following index anti-infectives: meropenem, teicoplanin, linezolid, piperacillin/tazobactam, levofloxacin and/oraciclovir
* Application of an ECLS procedure with an expected duration of at least five days
Exclusion Criteria:
* Pregnancy
* Massive Hemorrhage
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
99 Years
Study:
NCT04127305
Study Brief:
Protocol Section:
NCT04127305